Cowden Syndrome 1 (CWS1)
Alias:
Bannayan-Riley-Ruvalcaba Syndrome
Pten Hamartoma Tumor Syndrome
Lhermitte-Duclos Disease
Bannayan-Zonana Syndrome
Phts
Dysplastic Gangliocytoma of the Cerebellum
Ruvalcaba-Myhre-Smith Syndrome
Riley-Smith Syndrome
Myhre-Riley-Smith Syndrome
Brrs
Bzs
Ldd
Pten Hamartoma Tumor Syndrome with Granular Cell Tumor
Bannayan-Ruvalcaba-Riley Syndrome
Cerebelloparenchymal Disorder Vi
Hamartoma Syndrome, Multiple
Multiple Hamartoma Syndrome
Cws1
Mham
Rmss
Cs
Cd
Macrocephaly, Pseudopapilledema, and Multiple Hemangiomata
Macrocephaly Pseudopapilledema and Multiple Hemangiomata
Cerebellar Granule Cell Hypertrophy and Megalencephaly
Macrocephaly, Multiple Lipomas, and Hemangiomata
Macrocephaly Multiple Lipomas and Hemangiomata
Pten Hamartoma Tumor Syndromes
Ruvalcaba-Myhre Syndrome
Cowden Syndrome, Type 1
Cowden Syndrome
Cowden Disease
Bbrs
Cpd6
Basic Information
Medical Symptom
Gene & Mutation
Drugs
Disease Model
References
Cowden Syndrome 1, also known as bannayan-riley-ruvalcaba syndrome, is related to cowden syndrome 4 and cowden syndrome, and has symptoms including seizures, action tremor and cerebellar ataxia. An important gene associated with Cowden Syndrome 1 is PTEN (Phosphatase And Tensin Homolog), and among its related pathways/superpathways are Infectious disease and ERK Signaling. The drugs Everolimus and Temsirolimus have been mentioned in the context of this disorder. Affiliated tissues include cerebellum and skin, and related phenotypes are macrocephaly and seizure
Basic Information
Inheritance
Age Of Onset
Prevalence
Related Gene
Related Models
Reference
MALACARDS
AD
Newborn
<1/1000000
5
105
402
Medical Symptom
#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available
Gene & Mutation
#
Gene
Function
Score
Count
No data available
Drugs
Name
CAS Number
Status
Phase
No data available
Disease Model
Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available
References
Title
PMID
Journal
Year
IF
No Data Found!
Comparison
Al agent
Back to top